BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7931486)

  • 41. The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease.
    DiRaimondo F; Albitar M; Huh Y; O'Brien S; Montillo M; Tedeschi A; Kantarjian H; Lerner S; Giustolisi R; Keating M
    Cancer; 2002 Mar; 94(6):1721-30. PubMed ID: 11920534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia.
    Maďarová M; Mucha R; Hresko S; Makarová Z; Gdovinová Z; Szilasiová J; Vitková M; Guman T; Štecová N; Dobransky T
    Leuk Res; 2018 Jul; 70():25-33. PubMed ID: 29763855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble CD163 impact as a prognostic biomarker in chronic lymphocytic leukemia.
    Ragab HM; Attia HRM; Maksoud NA; Ibrahim MH; Mohamed MM; Kamel A; Sobeih ME; Kamal MAM; Abd Elaziz W
    Egypt J Immunol; 2023 Jul; 30(3):74-81. PubMed ID: 37440184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
    Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
    J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia.
    Leotard S; Chastang C; Travade P; Jaudon MC; Tournilhac O; Baudet S; Merle-Beral H
    Hematol J; 2000; 1(5):301-6. PubMed ID: 11920207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE.
    Inaoki M; Sato S; Takehara K
    J Dermatol Sci; 2004 Jun; 35(1):53-9. PubMed ID: 15194147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
    Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
    Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevation of soluble CD23 in serum from patients with blood eosinophilia.
    Aldebert D; Prin L; Dessaint JP; De Groote D; Capron A; Capron M
    Int Arch Allergy Immunol; 1994; 103(3):245-51. PubMed ID: 8111243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma.
    Dunphy CH; Wheaton SE; Perkins SL
    Mod Pathol; 1997 Aug; 10(8):818-22. PubMed ID: 9267825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
    Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
    Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study.
    Saberi Hosnijeh F; van der Straten L; Kater AP; van Oers MHJ; Posthuma WFM; Chamuleau MED; Bellido M; Doorduijn JK; van Gelder M; Hoogendoorn M; de Boer F; Te Raa GD; Kerst JM; Marijt EWA; Raymakers RAP; Koene HR; Schaafsma MR; Dobber JA; Tonino SH; Kersting SS; Langerak AW; Levin MD
    Exp Hematol; 2020 Sep; 89():55-60.e6. PubMed ID: 32781097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-G expression as a prognostic indicator in B-cell chronic lymphocytic leukemia.
    Attia MA; Nosair NA; Gawally A; Elnagar G; Elshafey EM
    Acta Haematol; 2014; 132(1):53-8. PubMed ID: 24557341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
    Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23.
    Dorfman DM; Pinkus GS
    Mod Pathol; 1994 Apr; 7(3):326-31. PubMed ID: 8058704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of sCD23 in atopic and nonatopic blood donors: correlation with age, total serum IgE, and allergic symptoms.
    Wilhelm D; Klouche M; Görg S; Kirchner H
    Allergy; 1994 Aug; 49(7):521-5. PubMed ID: 7825718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble CD23 (sCD23) serum levels and lymphocyte subpopulations in peripheral blood in rhinitis and extrinsic and intrinsic asthma.
    Sánchez-Guerrero I; Albaladejo MD; García-Alonso AM; Muro M; Hernández J; Alvarez MR
    Allergy; 1994 Sep; 49(8):587-92. PubMed ID: 7653734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis.
    Molica S; Levato D; Dell' Olio M; Cascavilla N; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
    Haematologica; 1997; 82(2):148-51. PubMed ID: 9175316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.
    Altun B; Erdem Y; Usalan C; Arici M; Haznedaroglu IC; Yasavul U; Turgan C; Caglar S; Kirazli S
    Clin Nephrol; 1999 Oct; 52(4):230-8. PubMed ID: 10543325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.
    Hallek M; Langenmayer I; Nerl C; Knauf W; Dietzfelbinger H; Adorf D; Ostwald M; Busch R; Kuhn-Hallek I; Thiel E; Emmerich B
    Blood; 1999 Mar; 93(5):1732-7. PubMed ID: 10029603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.